Drugs / KYG0395
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01588236 | May 2012 → Jul 2015 | primary dysmenorrhea | Jiangsu Kanion Pharmaceutical Co., Ltd | Completed | Mixed |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KYG0395 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01588236 ↗ |